ダイト(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4577/E24187 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2020/11/20 | 日証協 | 103,412株 | -14.17% | 700株 | -97.13% | 68,009株 | -30.96% | 17,239株 | +89.44% |
2020/11/13 | 日証協 | 120,480株 | +12.73% | 24,422株 | +72.05% | 98,509株 | -11.02% | 9,100株 | -60.09% |
2020/11/06 | 日証協 | 106,876株 | -10.32% | 14,195株 | +647.11% | 110,709株 | -5.06% | 22,800株 | +0.88% |
2020/10/30 | 日証協 | 119,181株 | -11.27% | 1,900株 | -93.12% | 116,609株 | -0.46% | 22,600株 | -38.83% |
2020/10/23 | 日証協 | 134,314株 | +16.27% | 27,605株 | +91.63% | 117,142株 | +13.72% | 36,948株 | +90.46% |
2020/10/16 | 日証協 | 115,519株 | -27.49% | 14,405株 | -7.66% | 103,007株 | -32.15% | 19,399株 | -3.97% |
2020/10/09 | 日証協 | 159,319株 | -29.91% | 15,600株 | +183.89% | 151,809株 | -33.53% | 20,200株 | -0.79% |
2020/10/02 | 日証協 | 227,310株 | -0.23% | 5,495株 | -40.91% | 228,395株 | +1.54% | 20,360株 | +2.07% |
2020/09/25 | 日証協 | 227,843株 | -0.14% | 9,300株 | -42.24% | 224,940株 | +1.31% | 19,948株 | +45.5% |
2020/09/18 | 日証協 | 228,172株 | -0.3% | 16,100株 | -87.69% | 222,030株 | -1.59% | 13,710株 | -90.92% |
2020/09/11 | 日証協 | 228,849株 | +97.93% | 130,805株 | +1194.46% | 225,625株 | +124.45% | 151,025株 | +488.75% |
2020/09/04 | 日証協 | 115,619株 | -1.3% | 10,105株 | -59.77% | 100,525株 | -1.58% | 25,652株 | +50.32% |
2020/08/28 | 日証協 | 117,145株 | -19.45% | 25,120株 | -74.63% | 102,138株 | -26% | 17,065株 | -62.34% |
2020/08/21 | 日証協 | 145,426株 | +16.17% | 99,000株 | +49.58% | 138,019株 | +12.91% | 45,315株 | +20.06% |
2020/08/14 | 日証協 | 125,182株 | -6.32% | 66,184株 | -17.68% | 122,238株 | -15.21% | 37,744株 | -59.84% |
2020/08/07 | 日証協 | 133,631株 | +16.94% | 80,400株 | +95.86% | 144,164株 | +42.1% | 93,992株 | +100.55% |
2020/07/22 | 日証協 | 113,336株 | +9.75% | 20,570株 | -50.82% | 95,932株 | -8.21% | 25,633株 | -69.84% |
2020/07/17 | 日証協 | 103,266株 | -20.89% | 41,823株 | +472.92% | 104,511株 | +3.49% | 84,998株 | +437.18% |
2020/07/10 | 日証協 | 130,536株 | +6.53% | 7,300株 | -62.23% | 100,991株 | +8.72% | 15,823株 | -39.02% |
※株式分割は考慮していませんのでご注意ください。
Page Top